Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies

Abstract

The MTG (Myeloid Translocation Gene) proteins are a family of novel transcriptional corepressors. We report that MTG16a, a protein isoform encoded by the MTG16 gene deranged by the t (16; 21) in myeloid malignancies, is targeted to the nucleolus. The amino acid sequence necessary for nucleolar localization was mapped to the MTG16a N-terminal region. MTG16a, like MTG8, the nuclear corepressor deranged by the t (8; 21), is capable to interact with specific histone deacetylases (HDACs) suggesting that the protein may mediate silencing of nucleolar gene transcription. In addition, MTG16a is capable to form oligomers with other MTG proteins. As a consequence of the t (16; 21) the AML1 DNA-binding domain replaces the MTG16a N-terminal region. The AML1-MTG16 fusion protein is targeted to the nucleoplasm where it is capable to oligomerize with MTG16a and interact with HDAC1 and HDAC3. The deficiency of HDAC-containing complexes at nucleolar sites and the accumulation of HDAC-containing complexes at AML1-sites may be critical in the pathogenesis of t (16; 21) myeloid malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Akhmanova A, Verkerk T, Langeveld A, Grosveld F, Galjart N . 2000 J. Cell Sci. 113: 4463–4474

  • Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW . 2001 Mol. Cell Biol. 21: 6470–6483

  • Anastassova-Kristeva M . 1977 J. Cell Sci. 25: 103–110

  • Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N . 1991 Blood 77: 2031–2036

  • Calabi F, Cilli V . 1998 Genomics 52: 332–341

  • Davis JN, Williams B, Herron JT, Galiano FJ, Meyers S . 1999 Oncogene 18: 1375–1383

  • Downing JR . 1999 Br. J. Haematol. 106: 296–308

  • Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H . 1992 Blood 80: 1825–1831

  • Evert BO, Wullner U, Schulz JB, Weller M, Groscurth P, Trottier Y, Brice A, Klockgether T . 1999 Hum. Mol. Genet 8: 1169–1176

  • Feinstein PG, Kornfeld K, Hogness DS, Mann RS . 1995 Genetics 140: 573–586

  • Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M . 1998 Blood 91: 4028–4037

  • Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA . 1998 Mol. Cell Biol. 18: 7185–7191

  • Gross CT, McGinnis W . 1996 EMBO J. 15: 1961–1970

  • Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E . 1991 EMBO J. 10: 3851–3859

  • Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB . 2001 J. Biol. Chem. 276: 9889–9895

  • Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M . 1998 Mol. Cell Biol. 18: 846–858

  • Kubota S, Copeland TD, Pomerantz RJ . 1999 Oncogene 18: 1503–1514

  • Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW . 1998a Mol. Cell Biol. 18: 7176–7184

  • Lutterbach B, Sun D, Schuetz J, Hiebert SW . 1998b Mol. Cell Biol. 18: 3604–3611

  • McClintock B . 1934 Zeit. Zellforsch. Mik. Anat. 21: 294–328

  • Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD . 2000 Mol. Cell Biol. 20: 2075–2086

  • Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, Bianchini A, Colombo E, Schiavoni I, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C, Pelicci PG . 2000 Mol. Cell 5: 811–820

  • Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M . 1993 EMBO J. 12: 2715–2721

  • Morohoshi F, Mitani S, Mitsuhashi N, Kitabayashi I, Takahashi E, Suzuki M, Munakata N, Ohki M . 2000 Gene 241: 287–295

  • Nisson PE, Watkins PC, Sacchi N . 1992 Cancer Genet. Cytogenet 63: 81–88

  • Pikaard CS . 2000 Trends Genet. 16: 495–500

  • Sacchi N, Schiaffonati L, Magnani I, Pappalardo C, Hughes Jr AJ, Darfler M, Hoogeveen AT . 1996 Oncogene 12: 437–444

  • Sacchi N, Tamanini F, Willemsen R, Denis-Donini S, Campiglio S, Hoogeveen AT . 1998 Oncogene 16: 2609–2615

  • Santoro R, Grummt I . 2001 Mol. Cell. 8: 719–725

  • Schmidt-Zachmann MS, Nigg EA . 1993 J. Cell. Sci. 105: 799–806

  • Shimada H, Ichikawa H, Nakamura S, Katsu R, Iwasa M, Kitabayashi I, Ohki M . 2000 Blood 96: 655–663

  • Siomi H, Shida H, Nam SH, Nosaka T, Maki M, Hatanaka M . 1988 Cell 55: 197–209

  • Sullivan GJ, Bridger JM, Cuthbert AP, Newbold RF, Bickmore WA, McStay B . 2001 EMBO J. 20: 2867–2874

  • Tamanini F, Kirkpatrick LL, Schonkeren J, Unen L, Bontekoe C, Bakker C, Nelson DL, Galjaard H, Oostra BA, Hoogeveen AT . 2000 Hum. Mol. Genet. 9: 1487–1493

  • Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM . 1998 Proc. Natl. Acad. Sci. USA 95: 10860–10865

  • Wood JD, Nucifora Jr FC, Duan K, Zhang C, Wang J, Kim Y, Schilling G, Sacchi N, Liu JM, Ross CA . 2000 J. Cell Biol. 150: 939–948

  • Zhai W, Comai L . 2000 Mol. Cell Biol. 20: 5930–5938

  • Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, Maccarana M, Minucci S, Pelicci PG, Lazar MA . 2001 Mol. Cell Biol. 21: 156–163

Download references

Acknowledgements

We are grateful to Dr Enzo Zimarino, DIBIT, Milan, Italy for his help with the inter-species hybrid assay. This work has been partially funded by an AIRC (Italy) award to N Sacchi. S Rossetti is sponsored by a Foreign Exchange Fellowship, University of Milan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoogeveen, A., Rossetti, S., Stoyanova, V. et al. The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies. Oncogene 21, 6703–6712 (2002). https://doi.org/10.1038/sj.onc.1205882

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205882

Keywords

This article is cited by

Search

Quick links